Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

114
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
114
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

109
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
109
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels01:31

Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels

258
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
258
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

154
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
154
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

186
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
186
Nonlinear Pharmacokinetics: Causes of Nonlinearity01:22

Nonlinear Pharmacokinetics: Causes of Nonlinearity

219
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
219

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Optimizing dalbavancin dosing for complicated methicillin-resistant Staphylococcus aureus infections: a multicentre population pharmacokinetic study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Emergence of dalbavancin non-susceptible methicillin-resistant Staphylococcus epidermidis (MRSE) in a patient treated with dalbavancin prolonged therapy: Case report, therapeutic drug monitoring and genomic characterization.

International journal of antimicrobial agents·2026
Same author

Case Commentary: When susceptibility is not enough in recurrent <i>Burkholderia cenocepacia</i> infection.

Antimicrobial agents and chemotherapy·2026
Same author

Genome sequence of a methicillin-resistant Staphylococcus epidermidis (MRSE) resistant to dalbavancin and teicoplanin isolated in Italy, 2023.

Journal of global antimicrobial resistance·2026
Same author

Gut microbiota profiling of the population residing in Friuli-Venezia Giulia through next-generation sequencing.

BMC microbiology·2026
Same author

Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers.

Antibiotics (Basel, Switzerland)·2026

相关实验视频

Updated: Jul 15, 2025

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

12.1K

梅罗胺PK/PD变异性和功能:"我们一起去"

Jacopo Angelini1,2, Simone Giuliano3, Sarah Flammini3

  • 1Clinical Pharmacology and Toxicology Institute, University Hospital Friuli Centrale ASUFC, 33100 Udine, Italy.

Pharmaceutics
|September 28, 2023
PubMed
概括

治疗药物监测 (TDM) 优化了美罗在现实环境中的剂量. 在TDM中发现,在64%的患者中,特别是患有功能障碍的患者中,需要进行显著的美罗胺剂量调整,以改善结果.

关键词:
抗生素 抗生素是一种抗生素.抗微生物耐药性 抗微生物耐药性临床药理学临床药理学不断输注的持续输注.危急的疾病危急的疾病.剂量优化剂量优化更多的是openemenem.药物动力学 药物动力学功能 功能 功能治疗药物监测 治疗药物监测

更多相关视频

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
06:48

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment

Published on: April 29, 2022

2.3K
Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
08:28

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug

Published on: December 14, 2021

8.4K

相关实验视频

Last Updated: Jul 15, 2025

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

12.1K
Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
06:48

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment

Published on: April 29, 2022

2.3K
Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
08:28

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug

Published on: December 14, 2021

8.4K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 传染性疾病 传染性疾病
  • 临床药房 临床药房

背景情况:

  • 梅罗是严重细菌感染的关键卡巴胺抗生素.
  • 治疗药物监测 (TDM) 对于优化美罗胺剂量至关重要,特别是在重症患者中.
  • 这项研究评估了美罗TDM对重症监护室以外的临床管理的影响.

研究的目的:

  • 评估美罗治疗药物监测 (TDM) 对实际临床环境中的剂量策略的影响.
  • 为了研究美罗胺暴露与患者功能之间的关系.
  • 为了确定需要调整梅罗胺剂量的患者子组.

主要方法:

  • 从2021年12月到2022年2月对195个美罗胺血清度 (Css) 的回顾性分析.
  • 基于美罗胺暴露水平 (治疗性,暴露不足,过度暴露) 的患者表征.
  • 功能与美罗胺Css之间的相关性分析,包括不同功能类别的剂量正常化暴露 (Css/D).

主要成果:

  • 只有36%的患者获得了治疗性美罗 Css (8-16 mg/L);64%需要剂量修改.
  • 在功能和美罗胺度之间发现了显著的相关性 (r = -0.7,p < 0.001).
  • 剂量正常化的美洛暴露 (Css/D) 与功能 (p < 0.001) 有显著差异,功能受损的暴露更高.

结论:

  • 在临床实践中,梅罗胺TDM为暴露不足的患者提供了必要的剂量调整.
  • 通过TDM优化美罗胺剂量可以提高抗生素的疗效并减轻耐药性风险.
  • 功能显著影响美洛暴露,即使在标准剂量调整的情况下,也需要TDM.